On June 30,2022,Foyou Pharma successfully listed on the main board of the A-share market under the stock code 601089. The company is primarily engaged in the research and development, production and sales of pharmaceutical preparations and medical devices. With the mission of "focusing on the pharmaceutical field ,co-creating a healthy life ", Foyou Pharma has developed a unique competitive advantage by integrating research, production and sales. The company will continue to create product portfolio, forming a rich product line with “field, product, technology” combination advantages, and constructing an industrial value chain covering the entire cycle from active pharmaceutical ingredients to drug preparations. Foyou Pharma has been selected as a G20 enterprise in the Beijing Pharmaceutical Industry Leapfrog Development Project, and ranked among China’s Top 100 Enterprises in Chemical Drug R&D, earning widespread acclaim within and beyond the industry.
The company has established a R&D strategy that is urgently needed in clinical practice and combines imitation and innovation, and is accelerating development in the field of innovative drugs. The company's product range is rich, with pharmaceutical formulations covering cardiovascular diseases, chronic kidney disease, skin diseases, digestive system, diabetes, mental and nervous system, gynecology, and hormones. The medical device business mainly focuses on clinical nursing products.
Foyou Pharma has established a nationwide sales network, bulit a professional ,highly efficient sales team dedicated to in-depth market expansion, and possesses a variety of marketing models with its own characteristics. The comprehensiveness of the sales network and the professionalism of the sales team provide a guarantee for the stable growth of the company's sales scale.
The company continuously expands its business dimensions and builds a new pattern for the development of the industry. Four major production bases have been formed in Tongzhou, Beijing; Cangzhou, Hebei; Xuancheng, Anhui; and Hangzhou, Zhejiang, and a production pattern covering the entire industrial chain of active pharmaceutical ingredients and preparations has been established.
Safety, efficacy and stability are the basic quality characteristics of drugs. We believe that quality originates from design and forms in production, and quality risk management should run through the whole product life cycle of product research and development, production, sales and delisting. Therefore, we define according to quality management, from the top design, architecture, establishing effective quality system and can guarantee the effective implementation of the quality policy, objectives, through quality planning, quality control, quality assurance and improvement measures, such as all the management activities to make the product quality effectively, the implementation of the orderly, and ensure that products are safe, effective and stable.
Based on the purpose of "providing high-quality products for the benefit of society", we adhere to the quality concept of "from design, excellent manufacturing, continuous improvement".
Product quality is a reliable basis for enterprises in the market competition, continuous improvement is to constantly improve the management system, constantly improve product quality and promote the development of enterprises.
Scientific management system, rigorous organizational structure, effective implementation of management, to ensure the full life cycle of medical and health products safe, effective and stable.
① The company's product research and development, production, sales process in line with quality management regulations and quality standards is the company's minimum requirements for products, our continuous technical progress, to ensure product quality excellence, technology and international synchronization or leading.
② Continue to improve product quality and enterprise quality management system, and gradually in line with international standards.
The teacher culture
The sage is the teacher and the master is the teacher
Create wealth for employees to benefit society
Innovation and competition
Seek truth and innovation, quality and efficiency
Balance of wealth creation is sustainable
Honesty, diligence and frugality
Follow the example, act prudently, act altruistically
Be an honest person and work steadily
Aim high and keep your feet on the ground
Top 50 Research and Development of Chemical Drugs 2024
Beijing Biopharmaceutical Industry Leapfrog Development Project (G20) - industry leader
High-tech enterprise
COPYRIGHT Beijing foyou Pharmaceutical Co., LTD. All rights reserved
EN
